US Broker Ratings

McKesson Corporation (MCK) Stock Analysis: Valuation Insights and Growth Potential in Healthcare Distribution

McKesson Corporation (NYSE: MCK), a titan in the healthcare distribution sector, continues to exhibit remarkable resilience and growth potential despite a complex market landscape. With a..

Veeva Systems Inc. (VEEV) Stock Analysis: Strong Buy Ratings Amid Robust Revenue Growth

Veeva Systems Inc. (NYSE: VEEV), a leader in cloud-based solutions tailored for the life sciences industry, presents a compelling investment opportunity. With a market capitalization of..

Thermo Fisher Scientific Inc. (TMO) Stock Analysis: A Leading Healthcare Giant with Strong Revenue Growth Prospects

Thermo Fisher Scientific Inc. (NYSE: TMO), a powerhouse in the healthcare sector, continues to capture the attention of investors with its robust market presence and influential..

Eli Lilly and Company (LLY) Stock Analysis: Exploring a Potential 14.46% Upside in the Healthcare Giant

Eli Lilly and Company (NYSE: LLY) stands as a towering figure in the healthcare sector with a market capitalization of $1.02 trillion. This Indianapolis-based pharmaceutical giant,..

Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a 5.91% Potential Upside in the Healthcare Giant

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, is capturing investor attention with its substantial market cap of $50.32 billion and a..

Medtronic plc (MDT) Stock Analysis: Unpacking a Potential 11.25% Upside in the Medical Device Sector

Medtronic plc (NYSE: MDT), a global leader in medical devices, offers a compelling investment opportunity for investors seeking exposure in the healthcare sector. With a market..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Titan with 4.29% Upside and Robust Buy Ratings

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the biotechnology sector, showcasing a market capitalization of $138.42 billion. Known for its innovative approach..

Haleon plc (HLN) Stock Analysis: Exploring a 24.94% Potential Upside in Healthcare Investment

Haleon plc (HLN), a prominent player in the healthcare sector, is capturing the attention of investors with its strong market presence and promising growth trajectory. With..

Danaher Corporation (DHR) Investor Outlook: A Strong ‘Buy’ with a 10% Upside Potential

Danaher Corporation, trading under the ticker DHR on the New York Stock Exchange, stands as a titan in the healthcare sector, specifically within the diagnostics and..

Boston Scientific Corporation (BSX) Stock Analysis: Exploring the 31% Potential Upside

Boston Scientific Corporation (NYSE: BSX) stands as a titan in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $69.27 billion,..

Atrium Therapeutics, Inc. (RNA)

⚠️ No article content returned.

..

Cytokinetics, Inc. (CYTK) Stock Analysis: A Biotech Powerhouse with 52.45% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK) stands out in the dynamic biotech sector, drawing investor interest with its innovative focus on muscle activators and inhibitors for treating serious..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: A 46% Upside Awaits in the Dynamic Cardiac Monitoring Market

iRhythm Holdings, Inc. (NASDAQ: IRTC) is carving out a significant niche in the healthcare sector, specifically within the medical devices industry. The company’s focus on digital..

RadNet, Inc. (RDNT) Stock Analysis: A Healthcare Play with 26.83% Potential Upside

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector specializing in diagnostics and research, presents a compelling opportunity for investors seeking growth in the..

Merit Medical Systems (MMSI) Stock Analysis: Exploring a 12% Upside Potential for Investors

Merit Medical Systems, Inc. (NASDAQ: MMSI), a key player in the healthcare sector specializing in medical instruments and supplies, is garnering investor interest with a promising..

Bio-Techne Corp (TECH) Stock Analysis: Evaluating the Balance Between Growth Potential and Current Valuation

Investors eyeing the biotechnology sector are likely familiar with Bio-Techne Corp (NASDAQ: TECH), a formidable player in the healthcare industry. With a market capitalization of $11.35..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a Promising 82% Potential Upside

ADMA Biologics Inc (NASDAQ: ADMA) captures the attention of investors with a compelling narrative in the healthcare sector, particularly within biotechnology. With a market cap of..

Legend Biotech (LEGN): Analyst Consensus Predicts a 147.72% Potential Upside in Biotech Stock

Legend Biotech Corporation (NASDAQ: LEGN) is emerging as a compelling player in the biotechnology sector, particularly for investors who are keen on the dynamic field of..

Teleflex Incorporated (TFX) Stock Analysis: Exploring Growth Potential with a 9.93% Upside

Teleflex Incorporated (NYSE: TFX), a key player in the healthcare sector, is making waves in the medical instruments and supplies industry. With a market capitalization of..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Potential Upside in Biotech Amidst Revenue Challenges

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a key player in the biotechnology sector, presents an intriguing opportunity for investors with a penchant for high-risk, high-reward ventures. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds